# PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

> **NCT01112527** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 58 (actual)

## Conditions studied

- Glioblastoma
- GBM
- Glioblastoma Multiforme

## Interventions

- **DRUG:** PF-00299804

## Key facts

- **NCT ID:** NCT01112527
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2018-08-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01112527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01112527, "PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01112527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*